Document Detail


Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone.
MedLine Citation:
PMID:  9829447     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This multicenter, randomized, double-masked, parallel-group, 24-week clinical study compared the efficacy of the combination of azelaic acid 20% cream and glycolic acid 15% or 20% lotion with hydroquinone 4% in the treatment of facial hyperpigmentation in darker-skinned patients. At week 24, overall improvement and reduction in lesion area, pigmentary intensity, and disease severity were comparable in the two treatment groups. At some visits, patients treated with an azelaic/glycolic acid combination had slightly greater levels of peeling, burning, stinging, or dryness than did patients treated with hydroquinone, although scores for cutaneous signs and symptoms were always low. The present study demonstrated that the combination of azelaic acid 20% cream and glycolic acid 15% or 20% lotion was as effective as hydroquinone 4% cream in the treatment of hyperpigmentation in darker-skinned patients, with only a slightly higher rate of mild local irritation. These findings suggest that the addition of glycolic acid to azelaic acid treatment for hyperpigmentation is an appropriate alternative in selected darker-skinned patients.
Authors:
L S Kakita; N J Lowe
Related Documents :
4066077 - Bioavailability of indomethacin capsules in humans (ii): correlation with dissolution r...
11702317 - Management of facial hyperpigmentation.
170347 - The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral ste...
8634807 - The combination of glycolic acid and hydroquinone or kojic acid for the treatment of me...
10698797 - Transient growth requirement in bacillus subtilis following the cessation of exponentia...
970997 - Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical therapeutics     Volume:  20     ISSN:  0149-2918     ISO Abbreviation:  Clin Ther     Publication Date:    1998 Sep-Oct
Date Detail:
Created Date:  1999-01-14     Completed Date:  1999-01-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7706726     Medline TA:  Clin Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  960-70     Citation Subset:  IM    
Affiliation:
Clinical Research Specialists, Santa Monica, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Dermatologic Agents / therapeutic use*
Dicarboxylic Acids / administration & dosage*,  adverse effects
Double-Blind Method
Drug Therapy, Combination
Female
Glycolates / administration & dosage*,  adverse effects
Humans
Hydroquinones / adverse effects,  therapeutic use*
Hyperpigmentation / drug therapy*
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Dermatologic Agents; 0/Dicarboxylic Acids; 0/Glycolates; 0/Hydroquinones; 123-31-9/hydroquinone; 123-99-9/azelaic acid; 79-14-1/glycolic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients.
Next Document:  Serum erythromycin levels in pregnancy.